Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1749-1757

  Lin, W W ^a   Chen, B C ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adenylyl cyclase; J774 macrophages; Protein kinase C; Pyrimidinoceptor; Uridine 5' triphosphate (UTP)

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; CYCLIC AMP; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; INOSITOL PHOSPHATE; IONOMYCIN; NUCLEOTIDE DERIVATIVE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E1; PROTEIN KINASE C; STAUROSPORINE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; ENZYME ACTIVITY; IMMUNOBLOTTING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ALPROSTADIL; ANIMALS; CALCIUM; CELLS, CULTURED; CYCLIC AMP; IONOMYCIN; ISOENZYMES; MACROPHAGES; MICE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOLS; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; VIRULENCE FACTORS, BORDETELLA;

EID: 0030759364     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701300     Document Type: Article

References (42)

1. 2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate response. Mol. Pharmacol., 38, 84-91.
2. 1 cells. J. Clin. Invest., 87, 1732-1738.
3. BARNARD, E.A., BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol. Sci., 15, 67-70.
4. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci., 16, 133-139.
5. BOUVIER, M. (1992). Cross-talk between second messengers. Ann. New York Acad. Sci., 594, 120-129.
6. BOYER, J.L., LAZAROWSKI, E.R., CHEN, X.-H. & HARDEN, T.K. (1993). Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase. J. Pharmacol Exp. Ther., 267, 1140-1146.
7. CHEN, J. & IYENGAR, R. (1993). Inhibition of cloned adenylyl cyclases by mutant-activated Giα and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment. J. Biol. Chem., 268, 12253-12256.
8. DEKKER, L.V. & PARKER, P.J (1994). Protein kinase C-a question of specificity. Trends Biochem. Sci., 19, 73-77.
9. FREDHOLM, B.B., BURNSTOCK, G., HARDEN, T.K. & SPEDDING, M. (1996). Receptor nomenclature. Drug. Dev. Res., 39, 461-466.
10. 2 receptors. Trends. Pharmacol. Sci., 18, 79-82.
11. 2 purine receptor interactions and surfactant secretion in primary cultures of type II cells. Am. J. Physiol., 261, L140-147.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
13. 2-purinergic receptors: subtype-associated signaling responses and structure. Ann. Rev. Pharmacol. Toxicol., 35, 541-579.
14. 2-purinoceptor mediated cyclic AMP formation in mouse C2C12 myotubes. Br. J. Pharmacol., 110, 133-138.
15. HUG, H. & SARRE, T.F. (1993). Protein kinase C isoenzymes: divergence in signal transduction? Biochem. J., 291, 329-343.
16. IYENGAR, R. (1993). Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J., 7, 768-775.
17. JACOBOWITZ, O. & IYENGAR, R. (1994). Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Natl. Acad. Sci. U.S.A., 91, 10630-10634.
18. JAKEN, S. (1996). Protein kinase C isozymes and substrate. Curr. Opinion Cell Biol., 8, 168-173.
19. KATADA, T., GILMAN, A.G., WATANABE, Y., BAUER, S. & JAKOBS, K.H. (1985). Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylyl cyclase. Eur. J. Biochem., 151, 431-437.
20. KAWABE, J., IWAMI, G., EBINA, T., OHNO, S., KATADA, T., UEDA, Y., HOMCY, C.J. & ISHIKAWA, Y. (1994). Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem., 269, 16554-16558.
21. LAZAROWSKl, E.R. & HARDEN, T.K. (1994). Identification of a nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem., 269, 11830-11836.
22. 6 glioma cells for mediating phosphoinositide turnover. J. Neurochem., 62, 536-542.
23. 6 glioma cells. J. Pharmacol. Exp. Ther., 269, 926-931.
24. 2 in RAW 264.7 macrophages. Br. J. Pharmacol., 119, 261-268.
25. MATSUOKA, I., ZHOU, Q., ISHIMOTO, H. & NAKANISHI, H. (1995). Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG 108-15 cells. Mol. Pharmacol., 47, 855-862.
26. MONS, N. & COOPER, D.M.F. (1995). Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci., 18, 536-542.
27. MORIMOTO, B.H. & KOSHLAND, D.E. (1994). Conditional activation of cAMP signal transduction by protein kinase C. J. Biol. Chem., 269, 4065-4069.
28. NISHIZUKA, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB J., 9, 484-496.
29. 2-Purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes. J. Biol. Chem., 262, 13483-13490.
30. 2 Purinergic receptor agonists enhance cAMP production in Madin-Barby canine kidney epithelial cells via an autocrine/paracrine mechanism. J. Biol. Chem., 271, 2029-2032.
31. SATO, K., OKAJIMA, F. & KONDO, Y. (1992). Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells. Activation of phospholipase C, and inhibition and activation of adenylate cyclase. Biochem. J., 283, 281-287.
32. SEIFERT, R. & SCHULTZ, G. (1989). Involvement of pyrimidinoceptors in the regulation of cell functions by urine and by uracil nucleotides. Trends Pharmacol. Sci., 10, 365-369.
33. SPRIGGS, D.R., DEUTSCH, S. & KUFE, D.W. (1991). Genomic structure, induction, and production of TNF-α. In The Cytokine Handbook. ed. Thompson, A.W. pp.1-34. London: Academic Press.
34. SUNAHARA, R.K., DESSAUER, C.W. & GILMAN, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Ann. Rev. Pharmacol. Toxicol., 36, 461-480.
35. 2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells. Eur. J. Pharmacol., 227, 25-31.
36. TAUSSIG, R., INIGUEZ-LLUHI, J.A. & GILMAN, A.G. (1993). Inhibition of adenylyl cyclase by Gi alpha. Science, 261, 218-221.
37. TAUSSIG, R. & GILMAN, A.G. (1995). Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem., 270, 1-4.
38. TOKUMITSU, Y., YANAGAWA, Y. & NOMURA, Y. (1991). Stimulation of DNA synthesis in Jurkat cells by synergistic action between adenine and guanine nucleotides. FEBS Lett., 288, 81-85.
39. WEBB, T.E., FEOLDE, E., VIGNE, P., NEARY, J.T., RUNBERG, A., FRELIN, C. & BARNARD, E.A. (1996). The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br. J. Pharmacol., 119, 1385-1392.
40. YAMADA, M., HAMAMORI, Y., AKITA, H. & YOKOYAMA, M. (1992). P2-purinoceptor activation stimulates phosphoinositide hydrolysis and inhibits accumulation of cAMP in cultured ventricular myocytes. Circ. Res., 70, 477-485.
41. YOSHIMASA, T., SIBLEY, D.R., BOVIER, M., LEFKOWITZ, R.J. & CARON, M.G. (1987). Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation. Nature, 327, 67-70.
42. YOSHIMURA, M. & COOPER, D.M.F. (1993). Type-specific stimulation of adenylylcyclase by protein kinase C. J. Biol. Chem., 268, 4604-4607.